Vaccine (and Other Biologic) Manufacturing Services for Infectious Diseases   3

Background
The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), supports research to understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports extramural research for the investigation, control, and prevention of diseases caused by all infectious agents. The NIAID requires a product development-oriented program to provide preclinical development support for multiple vaccine and biologic candidates.

Work Details
The purpose of the solicitation is to support the development of multiple vaccine and other biologic candidates as medical countermeasures against infectious diseases. The requested activities include product construction and development through the manufacture of clinical trial material to support Phase I/II clinical trials. The solicitation also seeks to support product assessments and product development plans focusing on activities required to support candidate entry into Phase I/II clinical trials. The NIAID anticipates awarding multiple IDIQ contracts to organizations that best meet the overall qualifications needed to fulfill the technical requirements of the Task Areas of the solicitation.

Period of Performance
The anticipated award will be an IDIQ Contract with a seven-year ordering period (10 years for Task Area A). The anticipated start date is on/or about May 1, 2025.